Published on

Toxicology – Penicillins and Cephalosporins


Core Concept


Penicillins and cephalosporins are β-lactam antibiotics. Acute oral overdose is usually mild, but important toxicity can occur with very large exposure, parenteral dosing errors, renal impairment, or hypersensitivity.


Major toxicologic concerns are:


  • GI upset
  • Hypersensitivity and anaphylaxis
  • Neurotoxicity → encephalopathy, myoclonus, seizures
  • Renal injury/crystalluria with selected agents
  • Electrolyte disturbances from certain formulations
  • Selected cephalosporin-associated coagulopathy
  • Rare hematologic and hepatic reactions


There is no specific antidote for β-lactam overdose.


⸻


Major Penicillins


Important examples include:


  • Penicillin G
  • Penicillin V
  • Amoxicillin
  • Ampicillin
  • Amoxicillin-clavulanate
  • Ampicillin-sulbactam
  • Flucloxacillin/dicloxacillin
  • Nafcillin
  • Oxacillin
  • Piperacillin-tazobactam


Some agents in older references, such as methicillin, carbenicillin, and ticarcillin, are now rarely used or unavailable in many regions.


⸻


Major Cephalosporins


Examples include:


  • Cephalexin
  • Cefazolin
  • Cefuroxime
  • Ceftriaxone
  • Cefotaxime
  • Ceftazidime
  • Cefepime
  • Cefixime
  • Cefpodoxime


Newer cephalosporin-containing therapies also exist, including agents active against resistant organisms.


Toxicity varies somewhat among individual drugs.


⸻


Mechanism


β-Lactams inhibit bacterial cell-wall synthesis by binding penicillin-binding proteins (PBPs) and interfering with peptidoglycan cross-linking.


This antibacterial mechanism does not directly explain most human toxicity.


⸻


Acute Oral Overdose


Most isolated oral exposures cause either no symptoms or:


  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal discomfort


A single historical dose threshold should not be used to determine whether toxicity will occur.


Risk assessment should instead consider:


  • Exact drug
  • Amount
  • Route
  • Renal function
  • Symptoms
  • Coingestants
  • Formulation
  • Patient-specific factors


⸻


1. Hypersensitivity


All β-lactams can produce allergic reactions.


Manifestations range from:


  • Mild maculopapular rash
  • Urticaria
  • Angioedema


to severe:


  • Bronchospasm
  • Upper-airway edema
  • Hypotension
  • Anaphylaxis


Importantly, allergic reactions are not dose dependent and can occur after relatively small therapeutic exposures.


⸻


Anaphylaxis


Possible findings include:


  • Urticaria/flushing
  • Angioedema
  • Wheezing
  • Stridor
  • Respiratory distress
  • Vomiting
  • Hypotension
  • Cardiovascular collapse


Epinephrine is first-line treatment for anaphylaxis.


Airway and circulatory support should occur simultaneously as required.


Antihistamines are only adjunctive treatments and must not delay epinephrine.


Routine H2-blocker treatment is no longer a central component of emergency anaphylaxis management.


⸻


Anaphylaxis – Important Update


The older recommendation for subcutaneous epinephrine is outdated.


For most anaphylaxis:


Intramuscular epinephrine is the preferred initial route.


IV epinephrine is reserved for selected severe refractory cases under closely monitored expert management because dosing errors can cause dangerous hypertension and dysrhythmias.


⸻


Penicillin–Cephalosporin Cross-Reactivity


The historical claim that patients with penicillin allergy have approximately a 10% risk of reacting to first-generation cephalosporins substantially overstates modern estimates.


Cross-reactivity depends importantly on:


  • Whether the original allergy was genuine
  • Type of reaction
  • β-lactam structure
  • R1 side-chain similarity


Many patients carrying a “penicillin allergy” label are not truly allergic.


⸻


Clinical Importance of Side Chains


Cross-reactivity is more likely when the penicillin and cephalosporin have similar side chains.


Therefore, β-lactam allergy assessment should be drug-specific, rather than assuming all penicillins and cephalosporins cross-react equally.


⸻


2. Neurotoxicity


β-Lactams can produce CNS toxicity, particularly when excessive concentrations accumulate.


Manifestations include:


  • Confusion
  • Agitation
  • Encephalopathy
  • Myoclonus
  • Hallucinations
  • Seizures
  • Nonconvulsive status epilepticus
  • Coma in severe cases


⸻


Mechanism of β-Lactam Neurotoxicity


At excessive CNS concentrations, β-lactams can interfere with inhibitory GABAergic neurotransmission.


This helps explain their proconvulsant effects.


⸻


Risk Factors for Neurotoxicity


Important risk factors include:


  • Renal impairment
  • Failure to adjust dose for kidney function
  • Older age
  • High parenteral doses
  • Preexisting CNS disease
  • Critical illness


Neurotoxicity during therapeutic use is therefore frequently a problem of drug accumulation, not intentional overdose.


⸻


Cefepime Neurotoxicity


Cefepime deserves particular attention.


Accumulation can produce:


  • Altered mental status
  • Encephalopathy
  • Aphasia
  • Myoclonus
  • Seizures
  • Nonconvulsive status epilepticus


Renal impairment is a major risk factor.


⸻


Recognizing Cefepime Neurotoxicity


Suspect it when a patient receiving cefepime—especially with reduced renal function—develops otherwise unexplained:


  • Confusion
  • Reduced consciousness
  • Myoclonus
  • Seizure activity


EEG may demonstrate abnormalities including patterns compatible with toxic-metabolic encephalopathy or nonconvulsive seizures.


Clinical context is essential because EEG findings are not specific to cefepime.


⸻


Management of β-Lactam Neurotoxicity


The major intervention is:


Stop or appropriately reduce the offending β-lactam and correct drug accumulation.


For seizures:


Benzodiazepines are first-line.


Persistent seizures may require additional benzodiazepines, phenobarbital, or appropriate anesthetic treatment for refractory status epilepticus.


Phenytoin is generally not preferred as routine treatment for toxicologic seizures.


⸻


3. Renal Toxicity


Several β-lactams can cause renal injury through different mechanisms.


These include:


  • Crystalluria/crystal nephropathy
  • Acute interstitial nephritis
  • Hemodynamic or multifactorial AKI during severe illness


⸻


Amoxicillin Crystal Nephropathy


High urinary concentrations of amoxicillin can produce crystal precipitation.


Possible consequences include:


  • Crystalluria
  • Hematuria
  • Flank discomfort
  • Oliguria
  • Acute kidney injury


Risk increases with high exposure and clinical circumstances favoring concentrated urine.


⸻


Ampicillin/Amoxicillin and AKI


Very high exposure may therefore produce renal dysfunction, but the mechanism should not simply be described as universal “tubular toxicity.”


Crystal-related obstruction and interstitial nephritis are important mechanisms to consider.


⸻


Acute Interstitial Nephritis


β-Lactams are recognized causes of drug-induced acute interstitial nephritis.


Possible findings include:


  • Rising creatinine
  • Hematuria
  • Pyuria
  • Proteinuria


The classic combination of:


fever + rash + eosinophilia


may occur but is absent in many patients.


⸻


Renal Evaluation


In significant exposure or symptomatic patients, consider:


  • Creatinine
  • BUN
  • Electrolytes
  • Urinalysis
  • Urine output


Renal function is especially important when neurologic toxicity is present because reduced clearance can markedly increase β-lactam concentrations.


⸻


4. Electrolyte Toxicity


Certain IV penicillin formulations contain substantial amounts of sodium or potassium.


Thus, toxicity may partly reflect the counter-ion rather than the antibiotic itself.


⸻


Potassium Penicillin G


Rapid or excessive administration of potassium-containing penicillin formulations can contribute to:


  • Hyperkalemia
  • Conduction abnormalities
  • Ventricular dysrhythmia
  • Cardiac arrest


This is mainly relevant to parenteral medication errors rather than ordinary oral penicillin exposure.


⸻


Sodium Load


High-dose sodium-containing β-lactam therapy can contribute to:


  • Sodium load
  • Fluid retention
  • Electrolyte disturbance


This is particularly relevant in patients with:


  • Heart failure
  • Renal dysfunction
  • Other conditions sensitive to sodium load


⸻


5. Cephalosporin-Associated Coagulopathy


Certain cephalosporins, particularly some containing an N-methylthiotetrazole (NMTT) side chain, can impair vitamin K–dependent coagulation.


Possible consequences include:


  • Prolonged PT/INR
  • Hypoprothrombinemia
  • Bleeding


Historically important agents include cefotetan and cefoperazone, among others.


⸻


Risk Factors for Coagulopathy


Risk increases with:


  • Malnutrition
  • Prolonged antibiotic therapy
  • Reduced vitamin K intake
  • Significant liver disease
  • Other causes of coagulopathy


This is generally a complication of therapeutic exposure rather than an acute single overdose.


⸻


Management of Cephalosporin Coagulopathy


Management includes:


  • Stop/reassess the causative drug
  • Measure coagulation studies
  • Correct vitamin K deficiency when present
  • Treat clinically significant bleeding using appropriate blood-product or factor replacement strategies


Routine prophylactic vitamin K is not required after every cephalosporin exposure.


⸻


6. Cephalosporins and Ethanol


Some NMTT-containing cephalosporins have historically been associated with a disulfiram-like reaction after alcohol exposure.


Possible symptoms include:


  • Flushing
  • Headache
  • Nausea
  • Vomiting
  • Tachycardia
  • Hypotension


This is agent-specific and should not be generalized to all cephalosporins.


⸻


7. Ceftriaxone


Ceftriaxone has several distinctive adverse effects.


These include:


  • Biliary sludge/pseudolithiasis
  • Rare immune hemolytic anemia
  • Precipitation interactions with calcium in specific clinical circumstances


These are therapeutic adverse effects rather than the expected syndrome after a simple acute ingestion.


⸻


Immune Hemolytic Anemia


Ceftriaxone can rarely cause severe immune-mediated hemolysis.


Possible findings include:


  • Sudden anemia
  • Pallor
  • Jaundice
  • Hemoglobinuria
  • Tachycardia
  • Hypotension


This can occasionally be severe and requires immediate discontinuation and supportive hematologic management.


⸻


8. Serum Sickness–Like Reaction


Cefaclor is particularly associated with serum sickness–like reactions, especially in children.


Features may include:


  • Fever
  • Rash
  • Arthralgia
  • Joint swelling


This differs from classic immune-complex serum sickness and usually improves after the offending medication is stopped.


⸻


9. Severe Cutaneous Reactions


Penicillins and cephalosporins can rarely produce severe delayed hypersensitivity syndromes such as:


  • Stevens–Johnson syndrome
  • Toxic epidermal necrolysis
  • DRESS
  • AGEP


These are not predictable from the size of an acute overdose.


⸻


Amoxicillin/Ampicillin Rash


A maculopapular rash is particularly common when aminopenicillins are given in the setting of certain viral illnesses, classically infectious mononucleosis.


Such a rash does not automatically establish an IgE-mediated penicillin allergy.


⸻


10. Procaine Penicillin Reaction


Procaine penicillin can rarely cause an acute neuropsychiatric syndrome historically termed the Hoigné syndrome.


Features may include:


  • Severe anxiety
  • Agitation
  • Confusion
  • Hallucinations
  • Perceptual disturbance
  • Seizure-like manifestations


It is associated with parenteral procaine penicillin administration rather than ordinary oral β-lactam poisoning.


⸻


GI Effects


The most common acute effects remain:


  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain


Antibiotic-associated alteration of intestinal flora can also lead to C. difficile infection, particularly after broader-spectrum or prolonged therapy.


⸻


Diagnosis


Determine:


  • Exact β-lactam
  • Formulation
  • Route
  • Amount
  • Time of exposure
  • Renal function
  • Allergy history
  • Other medications
  • Coingestants


In a patient receiving therapeutic β-lactams who develops new encephalopathy or seizures, specifically review whether dosing has been appropriately adjusted for renal function.


⸻


Laboratory Evaluation


No laboratory testing is usually required after a minor, uncomplicated oral exposure.


For significant toxicity, consider:


  • Glucose
  • Electrolytes
  • Potassium
  • Creatinine/BUN
  • CBC
  • Urinalysis


Additional testing is directed by the syndrome.


For example:


  • PT/INR when coagulopathy is suspected
  • Hemolysis studies for suspected ceftriaxone immune hemolysis
  • ECG with significant electrolyte abnormality or parenteral dosing error
  • EEG for unexplained encephalopathy/myoclonus or suspected nonconvulsive status


⸻


Serum β-Lactam Concentrations


Routine serum penicillin or cephalosporin concentrations are generally unnecessary in acute poisoning.


Clinical status and renal function are usually more informative.


Specialized therapeutic drug monitoring may be used in selected critically ill patients, but this is different from routine toxicology testing.


⸻


Laboratory Interference


Some older cephalosporins can interfere with certain laboratory assays, including older creatinine methodologies.


When laboratory results appear inconsistent with the clinical picture, analytical interference should be considered.


⸻


Initial Management


The general approach is:


Airway/breathing → circulation → identify drug and route → assess renal function → evaluate neurologic status → treat hypersensitivity/seizures/electrolyte abnormalities


Most acute oral exposures require only supportive care.


⸻


GI Decontamination


Do not induce vomiting.


Ipecac has no modern role.


Routine gastric lavage is obsolete.


Activated charcoal may occasionally be considered after a substantial recent ingestion when:


  • The drug is adsorbable
  • The airway is safe
  • Aspiration risk is low
  • Expected benefit justifies treatment


Because most isolated β-lactam ingestions are benign, charcoal is unnecessary in many cases.


⸻


Hypotension


Determine whether hypotension is caused by:


  • Anaphylaxis
  • Dehydration
  • Sepsis
  • Dysrhythmia
  • Coingestant


Appropriate isotonic crystalloid can be used when indicated.


Persistent vasodilatory shock generally favors norepinephrine.


Trendelenburg positioning and automatic dopamine-first therapy are outdated.


⸻


Anaphylaxis Management


Priorities include:


  • IM epinephrine first
  • Airway support
  • Oxygen when required
  • IV fluid resuscitation for hypotension
  • Bronchodilator for persistent bronchospasm


Antihistamines may improve cutaneous symptoms but are adjuncts only.


Corticosteroids do not provide immediate reversal of life-threatening anaphylaxis and should never delay epinephrine.


⸻


Enhanced Elimination


There is no single extracorporeal recommendation for every β-lactam.


Several β-lactams are substantially renally eliminated and some can be removed by hemodialysis.


This becomes most relevant when there is:


  • Severe renal failure
  • Marked drug accumulation
  • Severe persistent neurotoxicity
  • Conventional indications for dialysis


⸻


Cefepime and Dialysis


Hemodialysis can substantially enhance cefepime elimination.


In selected patients with severe cefepime neurotoxicity and markedly impaired renal clearance, dialysis may accelerate reduction of drug exposure.


However, the key first intervention remains discontinuation of cefepime and supportive management.


⸻


Monitoring


Monitoring should match the toxicity.


Significant neurotoxicity


  • Mental status
  • Seizure activity
  • Renal function
  • ECG/physiologic monitoring when severely ill


Renal toxicity


  • Creatinine
  • Electrolytes
  • Urine output
  • Urinalysis


Anaphylaxis


  • Airway
  • Oxygenation
  • Blood pressure
  • Recurrence of symptoms


Coagulopathy


  • PT/INR
  • Bleeding


⸻


Observation


A universal observation period is inappropriate.


Disposition depends on:


  • Drug
  • Route
  • Amount
  • Renal function
  • Symptoms
  • Allergy manifestations
  • Neurologic findings
  • Coingestants
  • Clinical trajectory


Renal impairment can substantially prolong β-lactam toxicity.


⸻


Admission


Hospitalization may be required for:


  • Anaphylaxis
  • Persistent hypotension
  • Airway compromise
  • Severe bronchospasm
  • Significant encephalopathy
  • Seizure
  • Nonconvulsive status epilepticus
  • Major electrolyte abnormality
  • AKI
  • Clinically important coagulopathy
  • Severe hematologic reaction


ICU care is appropriate for shock, status epilepticus, respiratory failure, or other severe organ dysfunction.


⸻


Pregnancy and Breastfeeding


The old FDA pregnancy letter categories are obsolete.


Penicillins and cephalosporins are among the most commonly used antibiotics during pregnancy, but treatment should still be individualized according to:


  • Specific agent
  • Infection
  • Maternal condition
  • Gestational stage
  • Allergy history


Many β-lactams enter breast milk in small amounts. Breastfeeding decisions should be drug-specific rather than based simply on detectable milk transfer.


⸻


Safeguarding


Rigid historical age thresholds for assuming abuse, neglect, or intentional poisoning are inappropriate.


Assess pediatric exposures according to:


  • Developmental capability
  • Medication access
  • Circumstances
  • Consistency of history
  • Recurrent events
  • Broader safeguarding concerns


⸻


Prognosis


Most isolated oral penicillin and cephalosporin overdoses resolve uneventfully.


Severe outcomes are more likely from:


  • Anaphylaxis
  • Parenteral medication errors
  • Severe renal impairment with drug accumulation
  • Cefepime-associated neurotoxicity
  • Major electrolyte abnormalities
  • Severe immune-mediated reactions


⸻


Important Modernization of the Older Source


  • Acute oral β-lactam overdose is usually mild and GI-predominant.
  • The historical oral threshold of 250 mg/kg should not be treated as a universal toxicity cutoff.
  • Allergic reactions are not dose dependent.
  • IM epinephrine is first-line for anaphylaxis; the older subcutaneous approach is outdated.
  • H1 antihistamines are adjuncts in anaphylaxis and must not delay epinephrine; routine H2 blockade is not central treatment.
  • The historical “10% penicillin-cephalosporin cross-allergy” figure substantially overstates overall modern cross-reactivity.
  • Cross-reactivity depends heavily on side-chain similarity and the nature of the original allergy.
  • Cefepime neurotoxicity is an important modern syndrome, especially with renal impairment.
  • β-lactam neurotoxicity can cause encephalopathy, myoclonus, seizures, and nonconvulsive status epilepticus.
  • Benzodiazepines are first-line for toxicologic seizures; phenytoin is generally not preferred.
  • High amoxicillin exposure can cause crystalluria and crystal nephropathy.
  • Selected cephalosporins can cause vitamin K–related coagulopathy, but this is not a universal cephalosporin effect.
  • Disulfiram-like reactions are agent-specific rather than a class effect.
  • Ceftriaxone can rarely cause severe immune hemolysis.
  • Flu-like aminopenicillin rashes do not automatically prove true IgE-mediated penicillin allergy.
  • Ipecac and routine gastric lavage are obsolete.
  • Trendelenburg and dopamine-first shock management are outdated.
  • Some β-lactams are dialyzable; dialysis may be particularly useful in selected severe accumulation with renal failure, including serious cefepime neurotoxicity.
  • Fixed observation periods should be replaced by agent-, renal-function-, symptom-, and trajectory-based assessment.
  • Historical FDA pregnancy categories are obsolete.


Key Points


  • Most acute oral penicillin/cephalosporin overdoses are mild.
  • Anaphylaxis can occur after very small exposures and is treated first with IM epinephrine.
  • Renal impairment greatly increases the risk of β-lactam neurotoxicity.
  • Cefepime → encephalopathy, myoclonus, seizures, and nonconvulsive status epilepticus.
  • Amoxicillin → crystal nephropathy after sufficiently high exposure.
  • Selected cephalosporins can cause coagulopathy, while ceftriaxone can rarely cause immune hemolysis.
  • Penicillin-cephalosporin cross-reactivity is much lower and more structurally specific than the historical 10% rule suggests.
  • There is no specific antidote.
  • Management is primarily supportive, complication-directed, and guided by renal function.


Image description
0 Comments